DDX43P2

Across TCGA pan-cancer cohorts, DDX43P2 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated DDX43P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DDX43P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DDX43P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRC, GBM, and MESO are the cancer types where DDX43P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
GBM	OS	Tertile	All	0.030	0.416	<.001	36	view →
MESO	DFS	Tertile	All	0.192	0.381	.013	27	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	18	view →
ESCA	DFS	Tertile	III,IV	1.000	0.277	.028	15	view →
HNSC	OS	Tertile	II,III,IV	0.291	0.610	.027	9	view →
SARC	OS	Tertile	All	0.560	0.781	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

DDX43P2–KIRC (DFS)

Open the KIRC breakdown →